Dermal Irritation, Sensitization, and Safety of Fixed-Dose Triple-Combination Clindamycin Phosphate 1.2%/Benzoyl Peroxide 3.1%/Adapalene 0.15% Gel in Healthy Participants

被引：0

作者：

Draelos, Zoe ^{[1
]}

Tanghetti, Emil ^{[2
]}

Gold, Linda Stein ^{[3
]}

Kircik, Leon ^{[4
]}

Bhatia, Neal ^{[5
]}

Zeichner, Joshua ^{[4
]}

Sugarman, Jeffrey ^{[6
]}

机构：

[1] Dermatol Consulting Serv PLLC, High Point, NC USA

[2] Ctr Dermatol & Laser Surg, High Point, NC USA

[3] Henry Ford Hosp, Detroit, MI USA

[4] Icahn Sch Med Mt Sinai, New York, NY USA

[5] Therapeut Clin Res, New York, NY USA

[6] Univ Calif San Francisco, San Francisco, CA USA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2023年 / 89卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

43390

引用

页码：AB33 / AB33

页数：1

共 50 条

[31] An Aqueous Gel Fixed Combination of Clindamycin Phosphate 1.2% and Benzoyl Peroxide 3.75% for the Once-Daily Treatment of Moderate to Severe Acne Vulgaris
Pariser, David M.
Rich, Phoebe
Cook-Bolden, Fran E.
Korotzer, Andrew
JOURNAL OF DRUGS IN DERMATOLOGY, 2014, 13 (09) : 1083 - 1089
[32] Therapeutics for the clinician: Adapalene-benzoyl peroxide once-daily, fixed-dose combination gel for the treatment of acne vulgaris: A randomized, bilateral (Split-Face), dose-assessment study of cutaneous tolerability in healthy participants
Andres, Philippe
Pernin, Colette
Poncet, Michel
CUTIS, 2008, 81 (03): : 278 - 284
[33] Efficacy and Safety of Tretinoin 0.025%/Clindamycin Phosphate 1.2% Gel in Combination With Benzoyl Peroxide 6% Cleansing Cloths for the Treatment of Facial Acne Vulgaris
Zeichner, Joshua A.
Haddican, Madelaine
Linkner, Rita V.
Wong, Vicky
JOURNAL OF DRUGS IN DERMATOLOGY, 2013, 12 (03) : 277 - 282
[34] Safety and cutaneous tolerability of a fixed combination clindamycin phosphate (1.2%) and low concentration benzoyl peroxide (2.5%) aqueous gel for the once-daily treatment of moderate to severe acne
Thiboutot, Diane
Shalita, Alan
Zaenglein, Andrea
Cortes, Roberto
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (03) : AB22 - AB22
[35] Fixed Combination of Clindamycin Phosphate 1.2% and Benzoyl Peroxide 3.75% Aqueous Gel: Long-Term Use in Adult Females With Moderate Acne Vulgaris
Kircik, Leon H.
JOURNAL OF DRUGS IN DERMATOLOGY, 2017, 16 (06) : 543 - 546
[36] Treatment of 2,453 Acne Vulgaris Patients Aged 12-17 Years With the Fixed-dose Adapalene-benzoyl Peroxide Combination Topical Gel: Efficacy and Safety
Eichenfield, Lawrence F.
Jorizzo, Joseph L.
Dirschka, Thomas
Taub, Amy Forman
Lynde, Charles
Graeber, Michael
Kerrouche, Nabil
JOURNAL OF DRUGS IN DERMATOLOGY, 2010, 9 (11) : 1395 - 1401
[37] Fixed-Dose Combination Gel of Adapalene and Benzoyl Peroxide plus Doxycycline 100 mg versus Oral Isotretinoin for the Treatment of Severe Acne: Efficacy and Cost Analysis
Penna, Pete
Meckfessel, Matthew H.
Preston, Norman
AMERICAN HEALTH AND DRUG BENEFITS, 2014, 7 (01): : 37 - 44
[38] An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 2.5% for the once-daily treatment of moderate to severe acne vulgaris: Assessment of efficacy and safety in 2813 patients
Thiboutot, Diane
Zaenglein, Andrea
Weiss, Jonathan
Webster, Guy
Calvarese, Barry
Chen, Diana
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 59 (05) : 792 - 800
[39] Treatment of Moderate Acne Vulgaris in Fitzpatrick Skin Type V or VI: Efficacy and Tolerability of Fixed Combination Clindamycin Phosphate 1.2%/Benzoyl Peroxide 3.75% Gel
Amar, Laetitia
Kircik, Leon H.
JOURNAL OF DRUGS IN DERMATOLOGY, 2018, 17 (10) : 1107 - 1112
[40] Impact of a Fixed Combination of Clindamycin Phosphate 1.2%-Benzoyl Peroxide 2.5% Aqueous Gel on Health-Related Quality of Life in Moderate to Severe Acne Vulgaris
Webster, Guy
Thiboutot, Diane M.
Chen, Diana M.
Merikle, Elizabeth
CUTIS, 2010, 86 (05): : 263 - 267

← 1 2 3 4 5 →